Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-12-27FDA Approved: JAIMIESS — Original Application (Xiromed, LLC.)
FDA approved the original application for JAIMIESS, a combined oral contraceptive, by Xiromed, LLC.
-
FDA approval · 2017-11-21FDA Approved: HAILEY FE 1/20 — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved HAILEY FE 1/20 as a generic oral contraceptive under an original ANDA, containing norethindrone acetate, ethinyl estradiol,…
-
FDA approval · 2017-10-10FDA Approved: LO LOESTRIN FE — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for LO LOESTRIN FE from Allergan, Inc. The product is a combination oral contraceptive used for …
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol [Phase 3]
Phase 3 clinical trial updating safety and efficacy of a contraceptive vaginal ring delivering Nestorone and Ethinyl Estradiol.
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System [Phase 3]
Phase 3 study updates the efficacy, safety and tolerability of Agile AG200-15 transdermal contraceptive system; completed with results poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm [Phase 3]
Phase 3 clinical trial update for a transdermal contraceptive patch (AG200-15) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy [Phase 4]
Phase 4 pharmacokinetic study evaluating etonogestrel implant in the context of antiretroviral therapy.
-
FDA approval · 2017-09-11FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for a generic fixed-dose combination of norethindrone acetate, ethinyl estradiol, and ferrous fumarate…
-
FDA approval · 2017-08-09FDA Approved: NUVARING — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for NuvaRing (etonogestrel and ethinyl estradiol) submitted by Advanz Pharma (US) Corp.
-
FDA approval · 2017-08-09FDA Approved: YAZ — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for YAZ, a combined oral contraceptive containing drospirenone and ethinyl estradiol, by Bayer H…
-
FDA approval · 2017-08-09FDA Approved: DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium (Sandoz).
-
FDA approval · 2017-08-09FDA Approved: SAFYRAL — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for SAFYRAL from Bayer HealthCare Pharmaceuticals. SAFYRAL is a combination oral contraceptive c…
-
FDA approval · 2017-08-09FDA Approved: LEVORA — Supplemental Application (Mayne Pharma Inc.)
FDA supplemental application approval for LEVORA (levonorgestrel and ethinyl estradiol) submitted by Mayne Pharma Inc.
-
FDA approval · 2017-08-09FDA Approved: PORTIA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for PORTIA, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submi…
-
FDA approval · 2017-08-09FDA Approved: ISIBLOOM — Supplemental Application (Xiromed, LLC.)
FDA approved a supplemental application for ISIBLOOM, a combination oral contraceptive containing desogestrel and ethinyl estradiol, manufac…
-
FDA approval · 2017-08-09FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves a supplemental application for Levonorgestrel and Ethinyl Estradiol by Lupin Pharmaceuticals, Inc., supporting its use as a com…
-
FDA approval · 2017-08-09FDA Approved: VALTYA 1/35 — Supplemental Application (Xiromed LLC)
FDA approved a supplemental application for VALTYA 1/35 (ethynodiol diacetate and ethinyl estradiol) by Xiromed LLC, enabling continued supp…
-
FDA approval · 2017-08-09FDA Approved: CHATEAL EQ — Supplemental Application (Afaxys Pharma, LLC)
FDA approves a supplemental application for CHATEAL EQ (levonorgestrel and ethinyl estradiol) by Afaxys Pharma, LLC.
-
FDA approval · 2017-08-09FDA Approved: VOLNEA — Supplemental Application (Xiromed, LLC.)
FDA approved a supplemental application for VOLNEA (desogestrel and ethinyl estradiol) from Xiromed, LLC.
-
FDA approval · 2017-08-09FDA Approved: AVIANE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for AVIANE, a fixed-dose combination oral contraceptive containing levonorgestrel and ethinyl es…
-
FDA approval · 2017-08-09FDA Approved: TAYTULLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for TAYTULLA (norethindrone acetate and ethinyl estradiol, and ferrous fumarate), updating its label…
-
FDA approval · 2017-08-09FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for LEVONORGESTREL AND ETHINYL ESTRADIOL from Mylan Pharmaceuticals Inc. The approval indicates an u…
-
FDA approval · 2017-08-09FDA Approved: LESSINA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for LESSINA (levonorgestrel and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2017-07-24FDA Approved: LEVORA — Supplemental Application (Mayne Pharma Inc.)
The FDA approved a supplemental application for LEVORA, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submi…
-
CLINICAL_TRIALS research · 2017-07-18Clinical Trial Update: Application for the Etonogestrel/Ethinyl Estradiol Ring [Phase 4]
This document provides an update on the Phase 4 clinical trial application for the etonogestrel/ethinyl estradiol vaginal ring, with the cur…